Garry Nolan Ph.D., Director at Akoya Biosciences, Inc. (AKYA), sold 100 shares at $13.25 ($1K) on 2022-12-13, disclosed to the SEC on 2023-03-27.
Open-market sale of $1k AKYA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKYA | SELL | 2022-12-02 | $67K | — | Filing → |
| AKYA | SELL | 2022-11-17 | $4K | — | Filing → |
| AKYA | SELL | 2022-11-14 | $375K | — | Filing → |